| Dr Elizabeth Prokos Berry | |
| 135 Main St, Ste 5, Sturbridge, Massachusetts 01566 | |
| (508) 347-7309 |
| Name | Dr Elizabeth Prokos Berry |
|---|---|
| Organization Name | Elizabeth Prokos Berry |
| Location | 135 Main St, Ste 5, Sturbridge, Massachusetts 01566 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (508) 347-7309 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New data on signalling proteins, called G proteins, may prove important in fighting diseases such as cardiovascular, neurodegenerative disorders, and cancer. For many decades scientists have puzzled on "How signalling proteins transport and organize in specific areas of the cell?" Researchers from Nano-Science Center and Department of Neuroscience and Pharmacology at the University of Copenhagen provide yet unrecognized clues to solve this mystery.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
Alcohol use disorder is a complex trait, both in its causes and characteristics. Individuals' sensitivity to alcohol can predict their risk of adverse alcohol outcomes like AUD. Further, AUD runs in families, reflecting in part a genetic component.
› Verified 2 days ago
| NPI Number | 1831376714 |
| Organization Name | ELIZABETH PROKOS BERRY |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 135 Main St, Sturbridge, MA 01566 |
| Phone Number | 508-347-7309 |
News Archive
New data on signalling proteins, called G proteins, may prove important in fighting diseases such as cardiovascular, neurodegenerative disorders, and cancer. For many decades scientists have puzzled on "How signalling proteins transport and organize in specific areas of the cell?" Researchers from Nano-Science Center and Department of Neuroscience and Pharmacology at the University of Copenhagen provide yet unrecognized clues to solve this mystery.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
Alcohol use disorder is a complex trait, both in its causes and characteristics. Individuals' sensitivity to alcohol can predict their risk of adverse alcohol outcomes like AUD. Further, AUD runs in families, reflecting in part a genetic component.
› Verified 2 days ago
News Archive
New data on signalling proteins, called G proteins, may prove important in fighting diseases such as cardiovascular, neurodegenerative disorders, and cancer. For many decades scientists have puzzled on "How signalling proteins transport and organize in specific areas of the cell?" Researchers from Nano-Science Center and Department of Neuroscience and Pharmacology at the University of Copenhagen provide yet unrecognized clues to solve this mystery.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
Alcohol use disorder is a complex trait, both in its causes and characteristics. Individuals' sensitivity to alcohol can predict their risk of adverse alcohol outcomes like AUD. Further, AUD runs in families, reflecting in part a genetic component.
› Verified 2 days ago
Cvs Pharmacy#10649 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 362 Main St, Sturbridge, Massachusetts 01566 Phone: (508) 347-7220 | |
Dr Elizabeth Prokos Berry Type: Eyewear Supplier (Equipment, not the service) Location: 135 Main St, Sturbridge, Massachusetts 01566 Phone: (508) 347-7309 | |
Monoplex Eye Prosthetics Llc Type: Prosthetic/Orthotic Supplier Location: 54 Main St, Sturbridge, Massachusetts 01566 Phone: (508) 347-3818 | |
Wal-mart Pharmacy 10-2797 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 Charlton Rd, Sturbridge, Massachusetts 01566 Phone: (508) 347-6344 | |
Walgreens#19506 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 182 Main St, Sturbridge, Massachusetts 01566 Phone: (508) 347-9936 |